Clara Burtenshaw, Neo Kuma Ventures, on shattering the stigma of psychedelic medication


Manage episode 296815175 series 2587257
著作 The Pulse by Wharton Digital Health の情報はPlayer FM及びコミュニティによって発見されました。著作権は出版社によって所持されます。そして、番組のオーディオは、その出版社のサーバから直接にストリーミングされます。Player FMで購読ボタンをタップし、更新できて、または他のポッドキャストアプリにフィードのURLを貼り付けます。
In this episode, we sat down with Clara Burtenshaw, Clara is a biotech and life sciences investor with significant transactional, VC, IP, and operational experience. We discussed: -The evolution of the psychedelics industry from a stigmatized counterculture phenomenon to a scientifically robust industry with support from the FDA for fast-tracking drug development -The clinical potential of psychedelics to treat illnesses ranging from mental illness to pain management and other nervous system disorders -Neo Kuma's focus on investing in early stage companies backed by sound science and building a strong founder network -Predictions that psychedelics as medication is here to stay, and the growing commercialization opportunities in the space

64 つのエピソード